NCT05903469 Implicit and Explicit Assessment of Suicide Risk
| NCT ID | NCT05903469 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | Implicit Association Test |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2022-06-28 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2022-06-28 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.
Eligibility Criteria
Inclusion Criteria: * Person presenting to emergencies for psychiatric reasons * Adult person * Free and informed consent signed * Person speaking and writing French fluently Exclusion Criteria: * Neurological disorders or major cognitive deterioration: presence of confusion * Acute psychotic decompensation * Troubled acute behavior * Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment * Adult under protective measure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05903469 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Implicit Association Test. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05903469 currently recruiting?
Yes, NCT05903469 is actively recruiting participants. Contact the research team at thilliez.jerome@chu-amiens.fr for enrollment information.
Where is the NCT05903469 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT05903469 clinical trial?
NCT05903469 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 108 participants.